PT1399144E - Compostos carbamato para utilizacao na prevencao ou tratamento de disturbios de ansiedade - Google Patents
Compostos carbamato para utilizacao na prevencao ou tratamento de disturbios de ansiedadeInfo
- Publication number
- PT1399144E PT1399144E PT02759750T PT02759750T PT1399144E PT 1399144 E PT1399144 E PT 1399144E PT 02759750 T PT02759750 T PT 02759750T PT 02759750 T PT02759750 T PT 02759750T PT 1399144 E PT1399144 E PT 1399144E
- Authority
- PT
- Portugal
- Prior art keywords
- group
- phenyl
- alkyl
- anxiety
- disturbances
- Prior art date
Links
- 208000019901 Anxiety disease Diseases 0.000 title abstract 2
- 230000036506 anxiety Effects 0.000 title 1
- 150000004657 carbamic acid derivatives Chemical class 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27168901P | 2001-02-27 | 2001-02-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1399144E true PT1399144E (pt) | 2006-07-31 |
Family
ID=23036639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT02759750T PT1399144E (pt) | 2001-02-27 | 2002-02-21 | Compostos carbamato para utilizacao na prevencao ou tratamento de disturbios de ansiedade |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US7078436B2 (pt) |
| EP (1) | EP1399144B1 (pt) |
| JP (1) | JP2004523554A (pt) |
| KR (1) | KR20030078947A (pt) |
| CN (1) | CN1503665A (pt) |
| AT (1) | ATE324107T1 (pt) |
| AU (1) | AU2002306567B2 (pt) |
| BR (1) | BR0207830A (pt) |
| CA (1) | CA2439286A1 (pt) |
| CY (1) | CY1107468T1 (pt) |
| CZ (1) | CZ20032311A3 (pt) |
| DE (1) | DE60210960T2 (pt) |
| DK (1) | DK1399144T3 (pt) |
| ES (1) | ES2262826T3 (pt) |
| HU (1) | HUP0303262A2 (pt) |
| IL (1) | IL157594A0 (pt) |
| MX (1) | MXPA03007720A (pt) |
| MY (1) | MY136391A (pt) |
| NO (1) | NO20033800L (pt) |
| NZ (1) | NZ546549A (pt) |
| PL (1) | PL364639A1 (pt) |
| PT (1) | PT1399144E (pt) |
| RS (1) | RS50505B (pt) |
| RU (1) | RU2292881C2 (pt) |
| WO (1) | WO2002067923A1 (pt) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004523554A (ja) * | 2001-02-27 | 2004-08-05 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 不安障害の予防もしくは治療における使用のためのカルバメート化合物 |
| KR20080025034A (ko) | 2005-01-20 | 2008-03-19 | 얀센 파마슈티카 엔.브이. | Ｑｔ 간격 조절 방법 |
| TWI419681B (zh) | 2005-06-08 | 2013-12-21 | Ｓｋ生物製藥股份有限公司 | 胺基甲酸酯用於製造供治療白天過度嗜睡（eds）的藥物之用途 |
| CA2667510A1 (en) * | 2006-10-27 | 2008-06-12 | Janssen Pharmaceutica N.V. | Methods for treating disruptive behavior disorders |
| US8263652B2 (en) * | 2007-10-31 | 2012-09-11 | Sk Biopharmaceuticals Co., Ltd. | Stabilized pediatric suspension of carisbamate |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| KR20160004260A (ko) * | 2013-03-12 | 2016-01-12 | (주)바이오팜솔루션즈 | 페닐카바메이트 화합물 및 이를 포함하는 신경보호용 조성물 |
| CN105228604A (zh) | 2013-03-12 | 2016-01-06 | 比皮艾思药物研发有限公司 | 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物 |
| CA3016253C (en) | 2016-02-29 | 2020-12-29 | Bio-Pharm Solutions Co., Ltd. | Sulfamate derivative compounds, processes for preparing them and their uses |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| KR102900173B1 (ko) * | 2016-12-14 | 2025-12-12 | 에스케이바이오팜 주식회사 | 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도 |
| EP3630072A4 (en) | 2017-06-02 | 2021-03-10 | Jazz Pharmaceuticals Ireland Limited | METHODS AND COMPOSITIONS FOR TREATMENT OF EXCESSIVE Drowsiness |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3278380A (en) * | 1962-02-06 | 1966-10-11 | Armour Pharma | Methods of calming employing diphenyl hydroxy carbamate compounds |
| US3248418A (en) | 1962-06-26 | 1966-04-26 | Charles D Bossinger | 2-hydroxy-2-phenyl alkyl carbamates |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| CN1109880A (zh) * | 1994-02-03 | 1995-10-11 | 合成实验室公司 | 3-(2-氨基乙基)-4-[3-(三氟甲基)苯甲酰基]-3，4-二氢-2h-1，4-苯并噁嗪衍生物、制备及其应用 |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| JP4276837B2 (ja) | 2001-02-27 | 2009-06-10 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 双極性障害の予防もしくは治療における使用のためのカルバメート化合物 |
| JP4276841B2 (ja) | 2001-02-27 | 2009-06-10 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 精神病性障害の予防もしくは治療における使用のためのカルバメート化合物 |
| JP2004523554A (ja) * | 2001-02-27 | 2004-08-05 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 不安障害の予防もしくは治療における使用のためのカルバメート化合物 |
-
2002
- 2002-02-21 JP JP2002567290A patent/JP2004523554A/ja active Pending
- 2002-02-21 PT PT02759750T patent/PT1399144E/pt unknown
- 2002-02-21 ES ES02759750T patent/ES2262826T3/es not_active Expired - Lifetime
- 2002-02-21 EP EP02759750A patent/EP1399144B1/en not_active Expired - Lifetime
- 2002-02-21 DK DK02759750T patent/DK1399144T3/da active
- 2002-02-21 MX MXPA03007720A patent/MXPA03007720A/es active IP Right Grant
- 2002-02-21 AU AU2002306567A patent/AU2002306567B2/en not_active Ceased
- 2002-02-21 CZ CZ20032311A patent/CZ20032311A3/cs unknown
- 2002-02-21 BR BR0207830-9A patent/BR0207830A/pt not_active IP Right Cessation
- 2002-02-21 DE DE60210960T patent/DE60210960T2/de not_active Expired - Lifetime
- 2002-02-21 CN CNA028087143A patent/CN1503665A/zh active Pending
- 2002-02-21 AT AT02759750T patent/ATE324107T1/de active
- 2002-02-21 US US10/081,713 patent/US7078436B2/en not_active Expired - Fee Related
- 2002-02-21 CA CA002439286A patent/CA2439286A1/en not_active Abandoned
- 2002-02-21 RS YUP-679/03A patent/RS50505B/sr unknown
- 2002-02-21 WO PCT/US2002/005423 patent/WO2002067923A1/en not_active Ceased
- 2002-02-21 RU RU2003128986/14A patent/RU2292881C2/ru not_active IP Right Cessation
- 2002-02-21 HU HU0303262A patent/HUP0303262A2/hu unknown
- 2002-02-21 PL PL02364639A patent/PL364639A1/xx not_active Application Discontinuation
- 2002-02-21 NZ NZ546549A patent/NZ546549A/en not_active IP Right Cessation
- 2002-02-21 IL IL15759402A patent/IL157594A0/xx unknown
- 2002-02-21 KR KR10-2003-7011293A patent/KR20030078947A/ko not_active Ceased
- 2002-02-27 MY MYPI20020693A patent/MY136391A/en unknown
-
2003
- 2003-08-26 NO NO20033800A patent/NO20033800L/no not_active Application Discontinuation
-
2005
- 2005-08-01 US US11/194,251 patent/US20050267203A1/en not_active Abandoned
-
2006
- 2006-06-21 CY CY20061100843T patent/CY1107468T1/el unknown
-
2009
- 2009-06-01 US US12/475,815 patent/US20090234003A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| YU67903A (sh) | 2006-08-17 |
| RU2292881C2 (ru) | 2007-02-10 |
| CY1107468T1 (el) | 2012-12-19 |
| HUP0303262A2 (hu) | 2004-01-28 |
| NO20033800D0 (no) | 2003-08-26 |
| RS50505B (sr) | 2010-03-02 |
| ATE324107T1 (de) | 2006-05-15 |
| AU2002306567B2 (en) | 2006-08-17 |
| KR20030078947A (ko) | 2003-10-08 |
| IL157594A0 (en) | 2004-03-28 |
| NZ546549A (en) | 2007-11-30 |
| US20090234003A1 (en) | 2009-09-17 |
| DE60210960D1 (de) | 2006-06-01 |
| CN1503665A (zh) | 2004-06-09 |
| MXPA03007720A (es) | 2004-11-12 |
| MY136391A (en) | 2008-09-30 |
| EP1399144B1 (en) | 2006-04-26 |
| ES2262826T3 (es) | 2006-12-01 |
| DK1399144T3 (da) | 2006-07-24 |
| EP1399144A1 (en) | 2004-03-24 |
| NO20033800L (no) | 2003-09-26 |
| RU2003128986A (ru) | 2005-03-20 |
| DE60210960T2 (de) | 2006-11-16 |
| BR0207830A (pt) | 2004-06-22 |
| CZ20032311A3 (cs) | 2005-02-16 |
| US20020143053A1 (en) | 2002-10-03 |
| CA2439286A1 (en) | 2002-09-06 |
| US20050267203A1 (en) | 2005-12-01 |
| WO2002067923A1 (en) | 2002-09-06 |
| PL364639A1 (en) | 2004-12-13 |
| US7078436B2 (en) | 2006-07-18 |
| HK1062270A1 (en) | 2004-10-29 |
| JP2004523554A (ja) | 2004-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU67703A (sh) | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja | |
| MY138156A (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
| NO20071921L (no) | Fremgangsmater for behandling av epileptogenese og epilepsi | |
| NO20080877L (no) | Fremgangsmater for behandling av substansrelaterte forstyrrelser | |
| PT1408953E (pt) | Compostos carbamato para utilizacao na prevencao ou tratamento do disturbio bipolar | |
| PT1399144E (pt) | Compostos carbamato para utilizacao na prevencao ou tratamento de disturbios de ansiedade | |
| MY133370A (en) | Carbamate compounds for use in preventing or treating bipolar disorders | |
| MY129312A (en) | Carbamate compounds for use in the treatment of pain | |
| PT1305082E (pt) | Compostos de carbamato para utilizacao na prevencao ou tratamento da dor neuropatica e dor associada a cefaleia de salvas e enxaqueca | |
| IL159847A0 (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain | |
| MY136733A (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| MY136347A (en) | Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |